How to Get Evenity (Romosozumab) in Alabama

What Evenity Is and Why Access Matters

Romosozumab is a monoclonal antibody that targets sclerostin, a protein produced by osteocytes that inhibits bone formation. By blocking sclerostin, Evenity both stimulates new bone formation and reduces bone resorption, a dual mechanism no other approved osteoporosis drug replicates. The FDA approved romosozumab in April 2019 for postmenopausal women at high risk for fracture (FDA approval label).

The Clinical Evidence Behind Romosozumab

In the ARCH trial (N=4,093), romosozumab for 12 months followed by alendronate reduced new vertebral fracture risk by 48% compared with alendronate alone over 24 months. The FRAME trial (N=7,180) showed romosozumab reduced new vertebral fractures by 73% versus placebo at 12 months.

The Boxed Warning

Evenity carries an FDA boxed warning for potential increased risk of myocardial infarction, stroke, and cardiovascular death. The American Association of Clinical Endocrinology (AACE 2020 guidelines) recommends against prescribing romosozumab in patients who have had a cardiovascular event within the past year. This warning shapes the lab work and screening your clinician will perform before writing a prescription.

Step-by-Step Prescription Process in Alabama

Getting Evenity in Alabama follows a predictable path. First, a qualified prescriber evaluates your fracture risk. Then labs are drawn and prior authorization is filed. The drug ships to your clinic or home, and you receive monthly injections for one year.

Step 1: Find a Qualified Prescriber

Alabama law permits MDs, DOs, nurse practitioners (NPs with full practice authority under Alabama Board of Nursing supervision agreements), and physician assistants (PAs) to prescribe Evenity. Endocrinologists and rheumatologists prescribe it most often. The Endocrine Society clinical practice guideline recommends romosozumab specifically for patients with very high fracture risk, defined as a recent osteoporotic fracture, a T-score of -3.0 or below, or a high FRAX score.

Step 2: Baseline Lab Work

Before prescribing, clinicians typically order a panel that includes serum calcium, 25-hydroxyvitamin D, basic metabolic panel (to assess renal function via eGFR), and a DEXA scan if one has not been performed within the past two years. The Evenity prescribing information requires correction of hypocalcemia before starting therapy. Vitamin D levels below 30 ng/mL should be repleted first.

Step 3: File Prior Authorization

Nearly every payer requires prior authorization for romosozumab. Documentation should include the DEXA T-score, FRAX calculation, fracture history, and evidence that bisphosphonates failed or are contraindicated. For Medicare Part B, Evenity is covered as a medical benefit under the physician fee schedule because it is administered by injection. Expect 5 to 15 business days for a determination from most insurers.

Telehealth Access in Alabama

Alabama permits telehealth prescribing of Evenity. Telehealth expanded significantly under Alabama Act 2022-256, which codified audio-video telehealth visits as an acceptable standard of care. A clinician licensed in Alabama can evaluate your fracture risk, order labs, and submit prior authorization remotely.

How a Telehealth Visit Works

You schedule a video consultation with a board-certified endocrinologist or rheumatologist. During the visit, the provider reviews your DEXA results, lab panels, and medical history. If romosozumab is appropriate, the provider writes the prescription electronically and initiates prior authorization. You then receive injections either at a local clinic or through a specialty pharmacy that coordinates home administration with a nurse visit.

Limitations of Telehealth for Evenity

The injection itself requires two subcutaneous shots (each prefilled syringe contains 105 mg for a total dose of 210 mg) and is typically administered by a healthcare professional. The AACE 2020 guideline) notes that while prescribing can occur via telehealth, administration should involve in-person supervision at least for the first dose. Some specialty pharmacies in Alabama arrange home nurse visits for ongoing injections.

Pharmacy and Distribution Options in Alabama

Evenity is a specialty biologic. You will not find it at a standard retail pharmacy. Distribution runs through specialty pharmacies, buy-and-bill physician offices, or hospital outpatient infusion centers.

Specialty Pharmacies

Major specialty pharmacies operating in Alabama include CVS Specialty, Accredo (Express Scripts), and OptumRx Specialty. These pharmacies handle prior authorization follow-up, cold-chain shipping, and patient education. Amgen's Evenity distribution page lists authorized specialty distributors.

503A Compounding Pharmacies

Alabama does license 503A compounding pharmacies under the Alabama Board of Pharmacy regulations. However, romosozumab is a patented biologic monoclonal antibody. No 503A pharmacy can legally compound a biosimilar version. Any claim that a compounding pharmacy can produce "compounded romosozumab" should be treated with extreme caution. The FDA guidance on biological products explicitly restricts compounding of biologics outside the 351(k) biosimilar pathway.

Buy-and-Bill Model

Many Alabama rheumatology and endocrinology practices use a buy-and-bill model: the clinic purchases Evenity directly, administers it, and bills your insurance under the medical benefit. This is the most common pathway for Medicare Part B patients. The clinic handles prior authorization, drug storage (Evenity requires refrigeration at 2 to 8 degrees Celsius per prescribing information), and injection.

Insurance Coverage and Cost in Alabama

Evenity costs roughly $1,825 per dose at wholesale, totaling approximately $21,900 for the full 12-month course. Coverage varies dramatically by payer.

Medicare Part B

Medicare Part B covers Evenity as a physician-administered drug. The beneficiary pays 20% coinsurance after meeting the Part B deductible. For a $1,825 dose, that is approximately $365 per month out-of-pocket without supplemental coverage. A Medigap plan or Medicare Advantage plan may reduce this further. CMS coverage determinations for osteoporosis drugs are outlined in the Medicare Benefit Policy Manual.

Commercial Insurance

Most commercial plans cover Evenity with prior authorization. The Amgen Assist 360 program offers eligible commercially insured patients a copay card that can reduce out-of-pocket costs to $0 per month. Eligibility requires commercial insurance (not government insurance) and a valid prescription.

Alabama Medicaid

Alabama Medicaid does not cover Evenity. Patients on Medicaid may explore the Amgen Safety Net Foundation, which provides Evenity at no cost to qualifying uninsured or underinsured patients with household income at or below 400% of the federal poverty level.

Comparing Payer Pathways

| Payer Type | Coverage Status | Typical Out-of-Pocket | PA Required | |---|---|---|---| | Medicare Part B | Covered | ~$365/month (20% coinsurance) | Yes | | Commercial (PPO/HMO) | Usually covered | $0, $150/month with copay card | Yes | | Alabama Medicaid | Not covered | Full cost or patient assistance | N/A | | Uninsured | Not covered | $1,825/month or $0 via Safety Net | N/A |

Prior Authorization Requirements in Alabama

Prior authorization for Evenity follows a consistent pattern across most Alabama payers. The documentation package your provider submits should include several components.

Required Documentation

A successful prior authorization submission includes a DEXA scan showing a T-score of -2.5 or lower at the lumbar spine, femoral neck, or total hip (ISCD official positions), plus documented history of osteoporotic fracture or a 10-year FRAX major osteoporotic fracture probability exceeding 20%. The insurer will also require evidence that the patient failed, was intolerant to, or has a contraindication to at least one oral bisphosphonate such as alendronate or risedronate. A cardiovascular risk assessment documenting no MI or stroke within 12 months is mandatory per the boxed warning.

Appeal Process

If denied, Alabama residents can file a first-level appeal with their insurer. Medicare patients can use the Medicare redetermination process within 120 days. Commercial patients should request a peer-to-peer review, where the prescribing physician speaks directly with the insurer's medical director. The American College of Rheumatology position statement on prior authorization emphasizes that delays in osteoporosis treatment increase fracture risk, which can strengthen the medical necessity argument.

Timeline: How Long Until You Receive Evenity in Alabama

Expect 2 to 4 weeks from initial prescriber visit to first injection. The breakdown:

• Prescriber evaluation and lab work: 1 to 5 days
• Prior authorization submission and approval: 5 to 15 business days
• Specialty pharmacy dispensing and shipping: 2 to 5 business days
• First injection appointment: scheduled upon drug arrival

If prior authorization is denied and an appeal is filed, add 15 to 30 days. Peer-to-peer reviews can accelerate this. A 2023 survey published in the Journal of Managed Care & Specialty Pharmacy found that 38% of osteoporosis biologic prior authorizations required at least one appeal.

Monitoring During Treatment

Once you start Evenity, your provider will monitor several parameters. The Endocrine Society guideline recommends checking serum calcium within the first month and rechecking at month 6 and month 12. Symptoms of hypocalcemia (muscle cramps, tingling, numbness) should prompt immediate lab evaluation.

Cardiovascular Monitoring

Given the boxed warning, the AACE 2020 guideline recommends baseline cardiovascular risk assessment and periodic reassessment during the 12-month treatment course. Blood pressure should be measured at each injection visit. Any new chest pain, neurological symptoms, or signs of ischemia warrant discontinuation and cardiology evaluation.

Post-Treatment Transition

Romosozumab is approved for only 12 monthly doses. Bone density gains reverse rapidly if no antiresorptive therapy follows. The ARCH trial protocol transitioned patients to alendronate after completing romosozumab. The ASBMR task force report strongly recommends sequential therapy with a bisphosphonate or denosumab after romosozumab to maintain the bone density gained.

Transferring a Prescription to Alabama

If you are moving to Alabama from another state, your existing romosozumab prescription can transfer. Alabama Board of Pharmacy regulations allow out-of-state prescriptions to be verified and filled by Alabama-licensed pharmacies. Your new provider in Alabama will need to re-verify your labs, confirm continued medical necessity, and potentially resubmit prior authorization to your new insurer. Most specialty pharmacies coordinate multi-state transfers within 5 to 7 business days.